We publish news about general health, articles about the department, announcements and events. You can also find ministerial media releases.
From 1 July 2018, the childhood immunisation schedule will be updated based on the advice on clinical experts.
Advice on the presence of natural rubber latex in the sheath covering the needle of the Fluad trivalent influenza vaccine. Anyone who has a severe allergy to latex should not receive Fluad.
The Australian Technical Advisory Group on Immunisation is consulting with stakeholders on proposed changes to meningococcal and Haemophilus influenzae type B vaccination recommendations for inclusion in the Australian Immunisation Handbook.
Annual influenza vaccination is recommended for all persons aged 6 months and over (unless contraindicated) to reduce their chance of becoming ill with influenza.
The Australian Technical Advisory Group on Immunisation (ATAGI) has provided advice regarding alternatives during supply shortage of the adult formulations of hepatitis B vaccines.
The Australian Technical Advisory Group on Immunisation (ATAGI) has developed advice for immunisation providers regarding the administration of 2018 seasonal influenza vaccines.
The Zostavax® vaccine is now available nationally for immunisation providers for people aged 70 to 79 years under the National Immunisation Program (NIP).
The Australian Technical Advisory Group on Immunisation (ATAGI) has new advice to support school based immunisation providers with the introduction of Gardasil®9 in a 2-dose schedule from January 2018.